CI 📈 Cigna - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1255231003

CI: Health Insurance, Pharmacy Benefits, Medicare Plans, Dental Insurance, Life Insurance

Cigna Group, a leading health services company, offers a diverse range of insurance and related products and services in the United States. Through its Evernorth Health Services segment, the company provides a comprehensive suite of health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and healthcare providers.

The company's Cigna Healthcare segment offers a wide array of products and services, including medical, pharmacy, behavioral health, dental, and other health insurance plans for insured and self-insured customers. Additionally, it provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans. Furthermore, Cigna offers health care coverage in its international markets, catering to mobile individuals and employees of multinational organizations.

In addition to its health insurance offerings, Cigna also provides permanent insurance contracts to corporations, enabling them to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through a multi-channel approach, including insurance brokers and consultants, direct sales to employers, unions, and other groups, or individuals, as well as private and public exchanges.

With a rich history dating back to 1792, Cigna Group is headquartered in Bloomfield, Connecticut, and has evolved over the years to become a prominent player in the health services industry. The company's commitment to providing innovative and customer-centric solutions has enabled it to maintain a strong presence in the market.

For more information, please visit Cigna Group's official website at https://www.cigna.com.

Additional Sources for CI Stock

CI Stock Overview

Market Cap in USD 91,810m
Sector Healthcare
Industry Healthcare Plans
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 1982-03-31

CI Stock Ratings

Growth 5y 63.2%
Fundamental 1.56%
Dividend 56.6%
Rel. Performance Sector 1.25
Analysts 4.48/5
Fair Price Momentum 327.73 USD
Fair Price DCF 482.17 USD

CI Dividends

Dividend Yield 12m 1.67%
Yield on Cost 5y 3.00%
Annual Growth 5y 161.81%
Payout Consistency 86.11%

CI Growth Ratios

Growth Correlation 3m -72.8%
Growth Correlation 12m 32.5%
Growth Correlation 5y 92.6%
CAGR 5y 12.42%
CAGR/Mean DD 5y 1.19
Sharpe Ratio 12m 0.98
Alpha 1.05
Beta 0.88
Volatility 27.57%
Current Volume 1524.7k
Average Volume 20d 1719k
What is the price of CI stocks?
As of December 04, 2024, the stock is trading at USD 334.90 with a total of 1,524,659 shares traded.
Over the past week, the price has changed by -0.03%, over one month by +7.23%, over three months by -8.01% and over the past year by +29.54%.
Is Cigna a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cigna is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.56 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CI as of December 2024 is 327.73. This means that CI is currently overvalued and has a potential downside of -2.14%.
Is CI a buy, sell or hold?
Cigna has received a consensus analysts rating of 4.48. Therefor, it is recommend to buy CI.
  • Strong Buy: 15
  • Buy: 7
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CI stock price target?
According to ValueRays Forecast Model, CI Cigna will be worth about 357.5 in December 2025. The stock is currently trading at 334.90. This means that the stock has a potential upside of +6.75%.
Issuer Forecast Upside
Wallstreet Target Price 399 19.1%
Analysts Target Price 332.9 -0.6%
ValueRay Target Price 357.5 6.8%